Gaingels Molecule LLC — Form D/A
Gaingels Molecule LLC of BURLINGTON, VT, a company, filed a Form D amendment with the SEC on 2023-01-27. The offering totals $246K, of which $246K was reported sold. Industry: Other.
Offering
- Filed: 2023-01-27
- Form: D/A
- Accession: 0001923844-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $246K
- Amount sold: $246K
- Minimum investment: $1K
- Investors: 22
- Date of first sale: 2022-05-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-446560
Issuer
- Name: Gaingels Molecule LLC
- CIK: 0001923844
- Entity type: Limited Liability Company
- Jurisdiction: VERMONT
- Incorporated: 2022
- Address: 3 MAIN STREET, BURLINGTON, VT, 05401
- Phone: 2124047343
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| David Beatty | Executive Officer | Burlington, VT |
Other filings by this issuer (1)
More